CN Patent

CN105848650A — 促进吸烟停止

Assigned to Jazz Pharmaceuticals International III Ltd · Expires 2016-08-10 · 10y expired

What this patent protects

本发明涉及使需要的对象停止或减少吸烟和/或咀嚼烟草或含烟碱产物的方法，所述方法包括给予所述对象有效量的某些氨基甲酸酯化合物。本发明还涉及防止需要的对象的吸烟和/或咀嚼烟草或含烟碱产物复发的方法，所述方法包括给予所述对象治疗有效量的某些氨基甲酸酯化合物。

USPTO Abstract

本发明涉及使需要的对象停止或减少吸烟和/或咀嚼烟草或含烟碱产物的方法，所述方法包括给予所述对象有效量的某些氨基甲酸酯化合物。本发明还涉及防止需要的对象的吸烟和/或咀嚼烟草或含烟碱产物复发的方法，所述方法包括给予所述对象治疗有效量的某些氨基甲酸酯化合物。

Drugs covered by this patent

solriamfetol-hydrochloride (SOLRIAMFETOL HYDROCHLORIDE)

Patent Metadata

Patent number: CN105848650A
Jurisdiction: CN
Classification: —
Expires: 2016-08-10
Drug substance claim: No
Drug product claim: No
Assignee: Jazz Pharmaceuticals International III Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.